Government Pension Fund Global (Norway) trimmed its stake in Sun Pharmaceutical Industries from 1.03% to 1.01%, selling 4,12,550 shares. At the current market price of ₹1,746.40, the transaction is valued at ₹72.05 crore.
A leading pharmaceutical manufacturer engaged in developing and marketing branded and generic formulations alongside Active Pharma Ingredients across global markets. The company operates multiple manufacturing facilities worldwide, serving customers through its extensive distribution network. Sun Pharma specializes in therapeutic areas including ophthalmology, cardiology, gastroenterology, and dermatology, combining research-driven innovation with broad-based generics production to serve patients in India and internationally.
Norway's sovereign wealth fund, managed by Norges Bank Investment Management. World's largest SWF with over USD 2 trillion in assets, invested across 8,700+ companies globally including Indian equities.
